Indaptus Therapeutics (INDP) Earnings Date & Reports

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

INDP is expected to report earnings to fall 40.62% to -18 cents per share on August 18

Indaptus Therapeutics INDP Stock Earnings Reports

Q2'25

Est.

$-0.19

Q1'25

Missed

by $0.14

Q4'24

Beat

by $0.10

Q3'24

Beat

by $0.16

Q2'24

Beat

by $0.11

The last earnings report on May 14 showed earnings per share of -31 cents, missing the estimate of -18 cents. With 95.70K shares outstanding, the current market capitalization sits at 5.45M.

View a ticker or compare two or three

Compare

INDP